Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies

por Eldehna, Wagdy M., Al-Rashood, Sara T., Al-Warhi, Tarfah, Eskandrani, Razan O., Alharbi, Amal, El Kerdawy, Ahmed M.
Publicado 2020

In silico identification of novel SARS-COV-2 2′-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches

por El Hassab, Mahmoud A., Ibrahim, Tamer M., Al-Rashood, Sara T., Alharbi, Amal, Eskandrani, Razan O., Eldehna, Wagdy M.
Publicado 2021

GC/MS Analysis of Essential Oil and Enzyme Inhibitory Activities of Syzygium cumini (Pamposia) Grown in Egypt: Chemical Characterization and Molecular Docking Studies

por El-Nashar, Heba A. S., Eldehna, Wagdy M., Al-Rashood, Sara T., Alharbi, Amal, Eskandrani, Razan O., Aly, Shaza H.
Publicado 2021

Targeting Transcriptional CDKs 7, 8, and 9 with Anilinopyrimidine Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and In Silico Studies

por Eskandrani, Razan, Al-Rasheed, Lamees S., Ansari, Siddique Akber, Bakheit, Ahmed H., Almehizia, Abdulrahman A., Almutairi, Maha, Alkahtani, Hamad M.
Publicado 2023

In silico identification of potential SARS COV-2 2′-O-methyltransferase inhibitor: fragment-based screening approach and MM-PBSA calculations

por El Hassab, Mahmoud A., Ibrahim, Tamer M., Shoun, Aly A., Al-Rashood, Sara T., Alkahtani, Hamad M., Alharbi, Amal, Eskandrani, Razan O., Eldehna, Wagdy M.
Publicado 2021

Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors 

por El Hassab, Mahmoud A., Eldehna, Wagdy M., Al-Rashood, Sara T., Alharbi, Amal, Eskandrani, Razan O., Alkahtani, Hamad M., Elkaeed, Eslam B., Abou-Seri, Sahar M.
Publicado 2022